Author

Jonathan Braverman

Innovative Genomics InstituteORCID 0000-0002-0759-7220Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Ömer H. YilmaziD· 2 shared David T. MyersiD· 1 shared Edmond WongiD· 1 shared Enbo MaiD· 1 shared Enzo Chen· 1 shared Ferran Fece de la CruziD· 1 shared George M. EngiD· 1 shared Haley BarnesiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ömer H. YilmazORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic dissection of DNA damage response pathways reveals divergent modulation of PD-1 blockade response in colorectal cancer

Ferran Fece de la Cruz, Edmond Wong, Haley Barnes, Katerina A. Fella, Jacquelyn M. Curtis, Sarah Phat, David T. Myers, Parasvi S. Patel, Jonathan Braverman, Ömer H. Yilmaz, Ryan Bruce Corcoran

This study identifies DDR gene alterations that modulate PD-1 blockade response in MSS colorectal cancer, showing that some defects enhance immunotherapy while others reduce benefit.

bioRxiv · Oct 6, 2026 · PreprintCancer Biology

Programming T cells for intercellular genome editing

Kevin M. Wasko, Madeleine Maker, Wayne Ngo, K X Chen, Enbo Ma, Rithu K. Pattali, Enzo Chen, Trevor Leung, Jonathan Braverman, Jennifer A. Doudna

This paper demonstrates T cells can deliver genome editing machinery to target cells via programmable intercellular interactions.

bioRxiv · Jun 23, 2026 · PreprintBioengineering

Leveraging WNT Hyperactivation to Kill Colorectal Cancer While Rejuvenating Healthy Intestine.

George M. Eng, Jonathan Braverman, Manish K. Gala, Ömer H. Yilmaz

This paper identifies a therapeutic strategy using WNT hyperactivation to kill colorectal cancer cells while rejuvenating healthy intestinal tissue.

bioRxiv · Oct 5, 2025 · PreprintCancer Biology